Studies like MIRACL have demonstrated an association between stroke risk and levels of high-sensitivity C-reactive protein (hs-CRP), serum amyloid A protein (SAA), and the inflammatory marker IL-6 (165). This evidence concerns the gene SAA1 and stroke disorder.